Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Laurus Labs Ltd.
NSE: LAURUSLABS
|
BSE: 540222
|
ISIN: INE947Q01028
|
Industry: Pharmaceuticals
|
Mid-range Performer
960.8000
-42.60
(
-4.25
%)
NSE
Mar 16, 2026
15:31 PM
85.61% Gain from 52W Low
Volume:
3.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Laurus Labs Ltd.
29 Apr 2024
960.80
-4.25%
Laurus Labs Limited
Neutral:
Laurus Labs Ltd.
by
Keynote Capitals Ltd
Target: 445
Recommendation
Target
Keynote Capitals Ltd
Quarterly Update Q4FY24
Laurus Labs has gained
67.37%
in the last 1 Year
More from Laurus Labs Ltd.
Recommended
IPO market remains active despite weak retail demand and a volatile market
|
16 Mar 2026, 05:41PM
Market closes higher on gains in banking, auto, and cement stocks
Trendlyne Marketwatch |
16 Mar 2026, 04:14PM
Earnings Call Transcript - Q1FY21 for Laurus Labs
|
31 Jul 2020